These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1080 related items for PubMed ID: 21317806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S, Austin RM, Dabbs D, Zhao C.
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [Abstract] [Full Text] [Related]

  • 3. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H, Mody RR, Luna E, Armylagos D, Xu J, Schwartz MR, Mody DR, Ge Y.
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.
    Rantshabeng PS, Tsima BM, Ndlovu AK, Motlhatlhedi K, Sharma K, Masole CB, Moraka NO, Motsumi K, Maoto-Mokote AKT, Eshetu AB, Tawe L, Gaolathe T, Moyo S, Kyokunda LT.
    BMC Infect Dis; 2024 Oct 15; 24(1):1163. PubMed ID: 39407130
    [Abstract] [Full Text] [Related]

  • 6. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C, Zhao S, Heider A, Austin RM.
    Arch Pathol Lab Med; 2010 Aug 15; 134(8):1130-5. PubMed ID: 20670132
    [Abstract] [Full Text] [Related]

  • 7. Follow up of atypical squamous cell Pap smears in Iraqi women.
    Pity IS, Shamdeen MY, Wais SA.
    Asian Pac J Cancer Prev; 2012 Aug 15; 13(7):3455-60. PubMed ID: 22994777
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F, Pulinthanathu R, Elgert P, Cangiarella J, Simsir A.
    Diagn Cytopathol; 2015 May 15; 43(5):381-7. PubMed ID: 25546355
    [Abstract] [Full Text] [Related]

  • 9. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Zuo T, Levi AW, Lin Q, Abi-Raad R, Adeniran AJ, Cai G.
    Am J Clin Pathol; 2021 Sep 08; 156(4):569-576. PubMed ID: 33728437
    [Abstract] [Full Text] [Related]

  • 10. Health disparities in cervical cancer: Prevalence of high-risk HPV and cytologic diagnoses according to race.
    Miller D, Morris CP, Maleki Z, White M, Rodriguez EF.
    Cancer Cytopathol; 2020 Nov 08; 128(11):860-869. PubMed ID: 32598100
    [Abstract] [Full Text] [Related]

  • 11. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May 08; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 12. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
    Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2008 May 08; 15(2):97-104. PubMed ID: 18573778
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D, Zhang H, Li J, Austin M, Wang T, Pradhan D, Zhao C.
    J Am Soc Cytopathol; 2020 May 08; 9(6):550-555. PubMed ID: 32475726
    [Abstract] [Full Text] [Related]

  • 16. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM.
    Cancer; 2007 Oct 25; 111(5):292-7. PubMed ID: 17879368
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM.
    Diagn Cytopathol; 2006 Oct 25; 34(10):707-10. PubMed ID: 16955480
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.